Eosinophile Atemwegsinflammation und „Small Airway Disease“ bei stabilen Patienten mit leichter COPD – Ergebnisse aus CAPTO-COPD
Mustafa Abdo(Heidelberg University), H Watz(LungenClinic Grosshansdorf), F Trinkmann(Hautklinik Heidelberg), Klaus F. Rabe(Christian-Albrechts-Universität zu Kiel), Frauke Pedersen, A. Kirsten(LungenClinic Grosshansdorf)
Cited by 0
Related Papers
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
Outcomes for COPD pharmacological trials: from lung function to biomarkers
|European Respiratory Journal|2008|856
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
|European Respiratory Journal|2017|679
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
|New England Journal of Medicine|2023|452
Factors Associated with Persistent Airflow Limitation in Severe Asthma
|American Journal of Respiratory and Critical Care Medicine|2001|360